Study of XL281 in Adults With Solid Tumors

NCT00451880 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Non-small-cell Lung Cancer
Colorectal Cancer
Papillary Thyroid Cancer
Melanoma

Interventions

DRUG: XL281
DRUG: famotidine

Sponsor

Exelixis